Stonepine Capital Management’s HilleVax HLVX Stock Holding History

Stonepine Capital Management’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-226,009	Closed	-$450K	–	66
2025 Q2	$450K	Sell	226,009 -12,941	-5%	-$23.7K	0.44%	42
2025 Q1	$346K	Buy	238,950 +106,603	+81%	+$197K	0.34%	43
2024 Q4	$274K	Buy	+132,347	New	+$249K	0.22%	44

Stonepine Capital Management's HLVX Position: Q3 2025 in Review

Stonepine Capital Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 226,009 shares — an estimated $450K sold.

Stonepine Capital Management first reported a position in HLVX in Q4 2024 and held it in 3 quarters. The position peaked at $450K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Stonepine Capital Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Stonepine Capital Management sold 226,009 HilleVax shares in Q3 2025, an estimated $450K.
Stonepine Capital Management first reported a position in HilleVax in Q4 2024 and held it in 3 quarters.
Stonepine Capital Management's HilleVax position peaked at $450K in Q2 2025.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Stonepine Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.